Back to Browse Journals » Patient Preference and Adherence » Volume 2

Patient’s compliance with allergen immunotherapy

Authors Cristoforo Incorvaia, Marina Mauro, Erminia Ridolo, Paola Puccinelli, Massimiliano Liuzzo, et al

Published 15 September 2008 Volume 2008:2 Pages 247—251

DOI http://dx.doi.org/10.2147/PPA.S3806

Review by Single-blind

Peer reviewer comments 3

Cristoforo Incorvaia1, Marina Mauro2, Erminia Ridolo3, Paola Puccinelli4, Massimiliano Liuzzo4, Silvia Scurati4, Franco Frati4,5

1Allergy/Pulmonary rehabilitation Unit, ICP Hospital, Milan, Italy; 2Allergy Unit, Sant’Anna Hospital, Como, Italy; 3University Department of Clinical Sciences, Parma, Italy; 4Medical and Scientific Department, Stallergenes, Milan, Italy; 5Pediatrics, University Department of Medical and Surgical Specialty and Public Health, Perugia, Italy

Background: Allergen immunotherapy (IT) is an effective treatment of respiratory allergy, but requires strict rules of performance. This makes compliance particularly relevant, but thus far only a few studies have investigated this issue.

Methods: We reviewed all the available articles on compliance and adherence with IT in its different forms of administration, ie, subcutaneous (SCIT), sublingual (SLIT), and local nasal (LNIT).

Results: Early studies, when only SCIT was available, reported a low compliance, ranging from 45% to 60%, but the demanding schedules used, with very frequent injections, accounted for this outcome, as shown by patients’ recognition of inconvenience as the major cause of noncompliance. The most recent studies reported a good compliance, estimated in 75% to 90%, to both SCIT and SLIT, inconvenience remaining the major cause of noncompliance, followed by cost of the treatment. The only study addressing LNIT found a very poor compliance (27%), the major cause being the side effects, with repeated nasal reactions to the allergen extract.

Conclusions: Adequate education of patients and optimization of administration schedules, with fine balancing between dose effectiveness and cost, are the factors most likely to achieve further improvement of compliance with IT.

Keywords: allergen immunotherapy, subcutaneous, sublingual, local nasal, compliance, adherence

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other articles by this author:

Effect of noninvasive mechanical ventilation in elderly patients with hypercapnic acute-on-chronic respiratory failure and a do-not-intubate order

Paolo Scarpazza, Cristoforo Incorvaia, Giuseppe di Franco, Stefania Raschi, Pierfranco Usai, et al

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:797-801

Published Date: 5 December 2008

Current and future applications of the anti-IgE antibody omalizumab

Cristoforo Incorvaia, Marina Mauro, Gian Galeazzo Riario-Sforza, Franco Frati, Francesco Tarantini, Maurizio Caserini

Biologics: Targets and Therapy 2008, 2:67-73

Published Date: 7 March 2008

Impairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium

Cristoforo Incorvaia, Gian Galeazzo Riario-Sforza, Chiara Pravettoni, Mona-Rita Yacoub, Franco Frati

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:123-126

Published Date: 7 March 2008

Readers of this article also read:

Pre- and postmortem imaging of transplanted cells

Andrzejewska A, Nowakowski A, Janowski M, Bulte JWM, Gilad AA, Walczak P, Lukomska B

International Journal of Nanomedicine 2015, 10:5543-5559

Published Date: 2 September 2015

Selective adherence to antihypertensive medications as a patient-driven means to preserving sexual potency

Corrine I Voils, Margarete Sandelowski, Philipp Dahm, Rachel Blouin, Hayden B Bosworth, et al

Patient Preference and Adherence 2008, 2:201-206

Published Date: 21 August 2008

A PDA-based dietary self-monitoring intervention to reduce sodium intake in an in-center hemodialysis patient

Mary Ann Sevick, Roslyn A Stone, Matthew Novak, Beth Piraino, Linda Snetselaar, et al

Patient Preference and Adherence 2008, 2:177-184

Published Date: 2 July 2008

Patients’ perception of diagnostic tests in the preoperative assessment of esophageal cancer

Marinke Westerterp, Henderik L van Westreenen, Marije Deutekom, Jaap Stoker, Paul Fockens, et al

Patient Preference and Adherence 2008, 2:157-162

Published Date: 30 April 2008

Association between perceived treatment adherence and health-related quality of life in children with juvenile idiopathic arthritis: perspectives of both parents and children

Karine Toupin April, Debbie Ehrmann Feldman, Maria Victoria Zunzunegui, Ciarán M Duffy

Patient Preference and Adherence 2008, 2:121-128

Published Date: 30 March 2008

Assessment of patient preference in allocation and observation of anti-tuberculosis medication in three districts in Tanzania

Saidi Egwaga, Nyagosya Range, Fred Lwilla, Abdallah Mkopi, Vivien Barongo, et al

Patient Preference and Adherence 2008, 2:1-6

Published Date: 5 February 2008